Sarilumab - AI vs. PFS - Question for Indijo

Indijo,

You may have addressed this previously. If so, my apologies.

As you know, Sanofi/Regeneron are currently conducting a Ph 3 study to assess the use of auto-injectors versus PFS's for the administration of Sarilumab. The estimated study completion date is March 2016. Reference: Clinicaltrials.gov Trial Record.

Interested in your thoughts. Any reason to believe (or not helieve) that the study is using Unilife auto-injectore and PFS's.

Thanks